These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 4686386

  • 1. Prostaglandin E2 and the luteal phase of the menstrual cycle: effects on blood progesterone, estradiol, cortisol, and growth hormone levels.
    Henzl MR, Ortega E, Cortés-Gallegos V, Tomlinson RV, Segre EJ.
    J Clin Endocrinol Metab; 1973 Apr; 36(4):784-7. PubMed ID: 4686386
    [Abstract] [Full Text] [Related]

  • 2. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG, Liu J, Ulmann A, Baulieu E, Yen SS.
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [Abstract] [Full Text] [Related]

  • 3. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
    Schaison G, George M, Lestrat N, Reinberg A, Baulieu EE.
    J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
    [Abstract] [Full Text] [Related]

  • 4. Intravenous infusion of prostaglandin F2alpha in the mid-luteal phase of the normal human menstrual cycle.
    Jewelewicz R, Cantor B, Dyrenfurth I, Warren MP, Vande Wiele RL.
    Prostaglandins; 1972 Jun; 1(6):443-51. PubMed ID: 4660079
    [No Abstract] [Full Text] [Related]

  • 5. Hormone levels during prostaglandin F 2 infusions for therapeutic abortion.
    Speroff L, Caldwell BV, Brock WA, Anderson GG, Hobbins JC.
    J Clin Endocrinol Metab; 1972 Mar; 34(3):531-6. PubMed ID: 5011257
    [Abstract] [Full Text] [Related]

  • 6. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
    Roseff SJ, Kettel LM, Rivier J, Burger HG, Baulieu E, Yen SS.
    Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
    [Abstract] [Full Text] [Related]

  • 7. Luteolysis in humans and subhuman primates.
    Henzl MR.
    Res Prostaglandins; 1972 May; 1(5):1-3. PubMed ID: 12337004
    [Abstract] [Full Text] [Related]

  • 8. The effect of prostaglandin F2 alpha infusion on corpus luteum function.
    Jones GS, Wentz AG.
    Am J Obstet Gynecol; 1972 Oct 01; 114(3):393-404. PubMed ID: 4637460
    [Abstract] [Full Text] [Related]

  • 9. Effect of prostaglandin F2alpha on the luteal phase of the cycle in nonpregnant women.
    Arrata WS, Chatterton RT.
    Am J Obstet Gynecol; 1974 Dec 01; 120(7):954-9. PubMed ID: 4429112
    [Abstract] [Full Text] [Related]

  • 10. Effect of indomethacin on estrogen-induced luteolysis in the ewe.
    Lewis PE, Warren JE.
    Prostaglandins; 1977 May 01; 13(5):957-63. PubMed ID: 866703
    [Abstract] [Full Text] [Related]

  • 11. Intraluteal infusion of a prostaglandin synthesis inhibitor, sodium meclofenamate, causes premature luteolysis in rhesus monkeys.
    Sargent EL, Baughman WL, Novy MJ, Stouffer RL.
    Endocrinology; 1988 Nov 01; 123(5):2261-9. PubMed ID: 3168922
    [Abstract] [Full Text] [Related]

  • 12. The effect of vaginally administered prostaglandin F2alpha on corpus luteum function.
    Bolognese RJ, Corson SL.
    Am J Obstet Gynecol; 1973 Sep 15; 117(2):240-5. PubMed ID: 4728875
    [Abstract] [Full Text] [Related]

  • 13. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB, Salvatierra AM, Romero C, Spitz IM.
    J Clin Endocrinol Metab; 1987 Dec 15; 65(6):1272-7. PubMed ID: 3119656
    [Abstract] [Full Text] [Related]

  • 14. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
    Puri CP, Laumas V, Agarwal N, Zoremthangi, Hingorani V, Laumas KR.
    Prostaglandins; 1977 Feb 15; 13(2):363-73. PubMed ID: 847240
    [Abstract] [Full Text] [Related]

  • 15. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
    Jewelewicz R, Dyrenfurth I, Ferin M, Bogumil J, Vande Wiele RL.
    J Clin Endocrinol Metab; 1977 Oct 15; 45(4):662-7. PubMed ID: 334788
    [Abstract] [Full Text] [Related]

  • 16. Effects of a luteinizing hormone-releasing hormone agonist on luteal function in women.
    Bergquist C, Nillius SJ, Wide L.
    Contraception; 1980 Sep 15; 22(3):287-93. PubMed ID: 7002443
    [Abstract] [Full Text] [Related]

  • 17. Serum ovarian steroids, prolactin and prostaglandin metabolites in women using the inert intrauterine device.
    Shalev E, Harpaz-Kerpel S, Engelhard Y, Weiner E, Eran A, Zuckerman H.
    Int J Gynaecol Obstet; 1987 Apr 15; 25(2):139-44. PubMed ID: 2884139
    [Abstract] [Full Text] [Related]

  • 18. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
    Sawin CT, Hershman JM, Boyd AE, Longcope C, Bacharach P.
    J Clin Endocrinol Metab; 1978 Dec 15; 47(6):1296-302. PubMed ID: 122427
    [Abstract] [Full Text] [Related]

  • 19. Effect of PGF2alpha in pseudopregnancy.
    Wentz AC, Rocco L, Jones GS.
    Obstet Gynecol; 1975 Jan 15; 45(1):49-55. PubMed ID: 1110819
    [Abstract] [Full Text] [Related]

  • 20. Plasma steroid and luteinizing hormone levels during prostaglandin F 2 administration in luteal phase of menstrual cycle.
    Hillier K, Dutton A, Corker CS, Singer A, Embrey MP.
    Br Med J; 1972 Nov 11; 4(5836):333-6. PubMed ID: 4637514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.